Key result
Low-molecular-weight heparin was the strongest independent predictor of acute allergic reactions during coronary angiography or PCI, increasing the risk 23.5-fold.
Why the study?
Allergic reactions during coronary angiography and PCI in ACS patients can affect outcomes, but their incidence and predictors in the catheterization laboratory required investigation.
Observational (n=1,812,994)
Yes
Acute allergic reactions during coronary angiography and PCI are rare and decreasing in incidence, but their occurrence is strongly predicted by the periprocedural use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors.
Answers are grounded in this paper and cite their sources.
Raises caution for LMWH in angiography/PCI due to allergic risk; observational data leave causality and practice implications open.
BACKGROUND: Allergic reactions during coronary angiography and percutaneous coronary intervention (PCI) in patients with acute coronary syndromes can affect their outcomes. AIMS: We aimed to investigate the incidence of allergic reactions and predictors of their occurrence in the catheterization laboratory. MATERIAL AND METHODS: The study included 1 812 994 treatment cases available in the ORPKI Polish National Registry, of which 659 372 were for women and 1 144 689 for men. Data were collected from 161 interventional cardiology centers in Poland between 2014 and 2022 and included in the retrospective analysis. An allergic reaction was defined as any hypersensitive response of the immune system manifesting as bronchospasm, asthma exacerbation, conjunctivitis, urticaria, eczema, angioedema, or anaphylactic shock. RESULTS: There was a decreasing incidence of allergic reactions overall, in both sexes and all age subgroups. The incidence of allergic reactions each year oscillated between 0.02% and 0.11% (P <0.001), and the most recent one was 0.02% in 2022. The incidence of allergic reaction was associated with low-molecular-weight heparin (LMWH) (OR, 23.5 [95% CI, 18.92-29.19]), glycoprotein IIb/IIIa inhibitors (GPI IIb/IIIa) (OR, 2.31 [95% CI, 1.92-2.78]), previous PCI (OR, 1.55 [95% CI, 1.34-1.8]), radiation dose (OR, 1.25 per 1000 mGy [95% CI, 1.19-1.31]), and contrast dose (OR, 1.17 per 100 ml [95% CI, 1.08-1.28]). CONCLUSIONS: The overall incidence of acute allergic reactions in the cath lab is low and decreased significantly between 2014 and 2022. The decrease in frequency did not depend on age or sex. Independent predictors of allergic reaction incidence were the use of GPI IIb/IIIa, LMWH, and dose of contrast agent and radiation.
No takes yet. Share an insight, caveat, or question.
Kaziród-Wolski et al. (2025) conducted an observational in Patients undergoing coronary angiography or percutaneous coronary intervention (PCI) (n=1,812,994). Low-molecular-weight heparin (LMWH) vs. No LMWH was evaluated on Occurrence of an allergic reaction in the catheterization laboratory (OR 23.5, 95% CI 18.92-29.19, p=<0.001). Low-molecular-weight heparin was the strongest independent predictor of acute allergic reactions during coronary angiography or PCI, increasing the risk 23.5-fold.
Synapse has enriched 10 related papers. Consider them for comparative context: